Twist Bioscience Responds to Agilent’s Latest Baseless Complaint

AUG 22, 2018 Download PDF Agilent’s wholesale shift in its allegations, two and a half years into its suit, reveals only the weakness of its claims. Agilent’s most recent allegations are gamesmanship, not substance.  They omit that more than four months before it sought to change its complaint, Twist informed – and provided to Agilent – the... Read more

Invitation to Roche's Virtual Pipeline Event: Key data for Roche's lung cancer portfolio to be presented at the 2018 IASLC World Conference on Lung Cancer

Basel, 22 August 2018 Invitation to Roche’s Virtual Pipeline Event: Key data for Roche’s lung cancer portfolio to be presented at the 2018 IASLC World Conference on Lung Cancer We are pleased to invite investors and analysts to participate in a live audio webcast and conference call on Tuesday, 25 September 2018, highlighting the results... Read more

Takara Bio entered into a licensing agreement relating to Oncolytic Virus "Canerpaturev" with Dong-A ST, South Korea

This article is translated from press release in Japanese for your convenience. Forward-Looking Statements Statements in this news release, other than those based on historical fact, concerning the current plans, prospects, strategies and expectations of the Company and its Group represent forecasts of future results. While such statements are based on the conclusions of management... Read more

Neogen’s one-hour Listeria Right Now™ receives AOAC approval

CONTACT: George Nagle, Neogen Corporation 517/372-9200 LANSING, Mich., Aug. 20, 2018 — Neogen’s revolutionary Listeria Right Now™ environmental pathogen detection system has officially achieved AOAC approval, license number #081802. The approval adds another level of assurance to the food safety community, as the product has now been validated by one of the industry’s leading third-party accreditation groups. “It’s extremely... Read more

Merck KGaA, Darmstadt, Germany, Awarded Australian CRISPR Nickase Patent for Foundational Genome-Editing Technology

Merck KGaA, Darmstadt, Germany, today announced that the Australian Patent Office has allowed the company’s patent application for the use of paired CRISPR nickases. 15 AUG 2018 | DARMSTADT, GERMANY Patent covers paired Cas9 nickase technology to reduce off-target effects, advance gene therapy and research Expands company’s foundational CRISPR cutting and integration IP necessary to correct genetic... Read more

Successfully certified

2018-08-10 Certifications are essential in international business. “Worldwide, and especially in Asia, customers are more and more looking for companies with comprehensive certifications,” explains Elisabeth Hofstätter-Kollarich, head of Quality & Management Systems at Anton Paar. Our company has been ISO 9001 certified for a long time, which confirms our high standards for the quality of... Read more

Fluidic Analytics Secures US Patent Paving the Way for the Development and Commercialization of Next-generation Protein Analysis Technology Platform

Cambridge, UK – (31 July 2018) Fluidic Analytics Ltd, has announced the issuance of US Patent 9,952,22 B2, entitled ‘Fluidic Separation and Detection’, from the United States Patent and Trademark Office. This paves the way for the development and commercialization of a next-generation protein analysis technology platform to be launched later this year. “The issuance... Read more

Takara Bio granted manufacturing license from the Swedish Medical Product Agency for clinical-grade human embryonic stem cell line derivation and banking

MOUNTAIN VIEW, Calif., July 25, 2018 /PRNewswire/ — Takara Bio announced today that the Medical Products Agency (“MPA”), the Swedish national authority responsible for regulation and surveillance of the development, manufacturing and marketing of drug and other medical products, granted a manufacturing license for derivation and banking of human embryonic stem (hES) cells to be produced under GMP... Read more